Omeros director granted 15,000 stock options
OMEROS CORP director Diana T. Perkinson received a grant of stock options covering 15,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OMEROS CORP director Diana T. Perkinson received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $10.28 per share and were awarded under the company’s non-employee director compensation policy in connection with the June 18, 2026 annual shareholder meeting.
The option grant will fully vest and become exercisable on the day before the 2027 annual shareholder meeting, as long as she continues serving as a director through that date. Following this award, she holds 15,000 stock options directly.
Insider Trade Summary
Grant/Award: 15,000 shares
Grant/Award
1 txn
Insider
Perkinson Diana T.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 15,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 15,000 contracts (Direct)
Footnotes (2)
- F1. Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
- F2. This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
Key Figures
Option grant size: 15,000 options
Exercise price: $10.28 per share
Expiration date: June 17, 2036
+1 more
4 metrics
Option grant size
15,000 options
Annual non-employee director award tied to June 18, 2026 meeting
Exercise price
$10.28 per share
Strike price for the 15,000 stock options
Expiration date
June 17, 2036
Option term end date
Post-transaction derivative holdings
15,000 options
Total stock options held directly after the grant
Key Terms
non-employee director compensation policy, stock option, vest, exercise price
4 terms
non-employee director compensation policy financial
"Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting..."
stock option financial
"each non-employee director ... is automatically granted an option to purchase 15,000 shares of common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "10.2800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did OMEROS CORP (OMER) report for Diana T. Perkinson?
OMEROS CORP reported a stock option grant to director Diana T. Perkinson. She received options for 15,000 shares of common stock as part of the non-employee director compensation policy tied to the annual shareholder meeting held on June 18, 2026.
How many stock options did the OMEROS (OMER) director receive and at what exercise price?
Diana T. Perkinson received 15,000 stock options at a $10.28 exercise price. Each option allows her to buy one share of OMEROS common stock at $10.28, regardless of the market price at the time she chooses to exercise, once vested.
When do Diana T. Perkinson’s OMEROS (OMER) stock options vest and become exercisable?
The stock options will fully vest the day before the 2027 annual shareholder meeting. Vesting is conditional on her continuing to serve as a director through that date, after which all 15,000 options become exercisable under the grant terms.
What policy governs the OMEROS (OMER) stock option grant to the non-employee director?
The grant is governed by Omeros Corporation’s non-employee director compensation policy. Under this policy, each qualifying non-employee director automatically receives an option to purchase 15,000 shares on the date of each annual shareholder meeting, subject to continued board service.
What is the expiration date of the OMEROS (OMER) stock options granted to Diana T. Perkinson?
The granted stock options expire on June 17, 2036. She may exercise vested options any time before that expiration date, subject to the company’s equity plan rules and her continued eligibility under the terms of the award.
Is the OMEROS (OMER) director’s option grant an open-market purchase or compensation award?
The transaction is a compensation-related stock option award, not an open-market purchase. It was automatically granted pursuant to the company’s non-employee director compensation policy in connection with the 2026 annual shareholder meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates